» Articles » PMID: 9639375

Myocyte Recovery After Mechanical Circulatory Support in Humans with End-stage Heart Failure

Overview
Journal Circulation
Date 1998 Jun 25
PMID 9639375
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The failing myocardium is characterized by decreased force production, slowed relaxation, and depressed responses to beta-adrenergic stimulation. In some heart failure patients, heart function is so poor that a left ventricular assist device (LVAD) is inserted as a bridge to transplantation. In the present research, we investigated whether circulatory support with an LVAD influenced the functional properties of myocytes from the failing heart.

Methods And Results: Myocytes were isolated from human explanted failing hearts (HF-myocytes) and failing hearts with antecedent LVAD support (HF-LVAD-myocytes). Studies of myocyte function indicated that the magnitude of contraction was greater (9.6+/-0.7% versus 6.9+/-0.5% shortening), the time to peak contraction was significantly abbreviated (0.37+/-0.01 versus 0.75+/-0.04 seconds), and the time to 50% relaxation was reduced (0.55+/-0.02 versus 1.45+/-0.11 seconds) in the HF-LVAD-myocytes compared with the HF-myocytes (P<0.05). The HF-LVAD-myocytes had larger contractions than the HF-myocytes at all frequencies of stimulation tested. The negative force-frequency relationship of the HF-myocytes was improved in HF-LVAD-myocytes but was not reversed. Responses to beta-adrenergic stimulation (by isoproterenol) were greater in HF-LVAD-myocytes versus HF-myocytes.

Conclusions: The results of the study strongly support the idea that circulatory support with an LVAD improves myocyte contractile properties and increases beta-adrenergic responsiveness.

Citing Articles

Nuclear ATP-citrate lyase regulates chromatin-dependent activation and maintenance of the myofibroblast gene program.

Lazaropoulos M, Gibb A, Chapski D, Nair A, Reiter A, Roy R Nat Cardiovasc Res. 2024; 3(7):869-882.

PMID: 39196175 PMC: 11358007. DOI: 10.1038/s44161-024-00502-3.


Cardiac mechanics and reverse remodelling under mechanical support from left ventricular assist devices.

Pamias-Lopez B, Ibrahim M, Pitoulis F Front Cardiovasc Med. 2023; 10:1212875.

PMID: 37600037 PMC: 10433771. DOI: 10.3389/fcvm.2023.1212875.


Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support.

Drakos S, Badolia R, Makaju A, Kyriakopoulos C, Wever-Pinzon O, Tracy C Circulation. 2022; 147(5):409-424.

PMID: 36448446 PMC: 10062458. DOI: 10.1161/CIRCULATIONAHA.121.056600.


Myocardial recovery following durable left ventricular assist device support.

Rao V, Billia F JTCVS Open. 2022; 8:1-5.

PMID: 36004137 PMC: 9390417. DOI: 10.1016/j.xjon.2021.10.005.


Glutamine uptake and catabolism is required for myofibroblast formation and persistence.

Gibb A, Huynh A, Gaspar R, Ploesch T, Lombardi A, Lorkiewicz P J Mol Cell Cardiol. 2022; 172:78-89.

PMID: 35988357 PMC: 10486318. DOI: 10.1016/j.yjmcc.2022.08.002.